Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03455192Completed
Randomised, double-blind trial (2 arms), sponsored by Kırıkkale University. Primary endpoints: Interleukin-6 level of Gingival Crevicular Fluid at 2 months, Interleukin-8 level of Gingival Crevicular Fluid at 2 months and 1 more. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03455192.